PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $654 | -29.1% | 994,399 | +1.6% | 0.00% | 0.0% |
| Q2 2023 | $922 | -0.2% | 979,095 | +1.5% | 0.00% | 0.0% |
| Q1 2023 | $924 | -43.8% | 964,900 | -19.0% | 0.00% | -50.0% |
| Q4 2022 | $1,644 | -99.9% | 1,191,150 | -5.6% | 0.00% | 0.0% |
| Q3 2022 | $1,577,000 | -34.8% | 1,261,400 | +23.0% | 0.00% | -33.3% |
| Q2 2022 | $2,420,000 | +0.6% | 1,025,605 | +32.2% | 0.00% | 0.0% |
| Q1 2022 | $2,405,000 | -20.4% | 775,900 | +63.1% | 0.00% | -25.0% |
| Q4 2021 | $3,020,000 | +127.6% | 475,600 | +257.1% | 0.00% | +100.0% |
| Q3 2021 | $1,327,000 | +55.9% | 133,200 | +107.2% | 0.00% | +100.0% |
| Q2 2021 | $851,000 | +157.9% | 64,300 | +155.2% | 0.00% | – |
| Q3 2020 | $330,000 | – | 25,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $15,375,000 | 15.35% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $3,831,000 | 4.65% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $7,744,000 | 3.82% |
| Frazier Life Sciences Management, L.P. | 5,009,219 | $15,529,000 | 1.32% |
| Deep Track Capital, LP | 3,375,000 | $10,463,000 | 0.67% |
| Orbimed Advisors | 7,331,999 | $22,729,000 | 0.37% |
| Lynx1 Capital Management LP | 105,504 | $327,000 | 0.30% |
| XTX Topco Ltd | 94,309 | $292,000 | 0.13% |
| Woodline Partners LP | 1,913,880 | $5,933,000 | 0.10% |
| GREAT POINT PARTNERS LLC | 113,900 | $353,000 | 0.08% |